Carbogen Amcis (Shanghai) completed ANVISA Audit
A five-day inspection was concluded successfully with no critical and no major observations raised
A five-day inspection was concluded successfully with no critical and no major observations raised
ANVISA issues CGMP to Concord Biotech’s Unit I
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The approval allows it to market its products in the country
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
Subscribe To Our Newsletter & Stay Updated